2269
COM:WUXIBIOLOGICS
WuXi Biologics
- Stock
Last Close
16.08
14/11 01:29
Market Cap
46.18B
Beta: -
Volume Today
68.06M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 49.01M - | 65.40M 33.44% | 175.85M 168.87% | 303.69M 72.70% | 737.72M 142.92% | 1.13B 52.72% | 1.97B 74.48% | 3.99B 103.13% | 5.36B 34.18% | 3.40B 36.55% | |
depreciation and amortization | 42.31M - | 57.01M 34.74% | 93.19M 63.47% | 122.75M 31.73% | 143.77M 17.13% | 221.37M 53.97% | 303.01M 36.88% | 481.78M 59.00% | 800.67M 66.19% | ||
deferred income tax | -64.52M - | -221.85M 243.85% | -567.11M 155.62% | ||||||||
stock based compensation | 4.77M - | 26.86M 463.60% | 47.55M 77.03% | 65.08M 36.86% | 128.37M 97.27% | 203.94M 58.86% | 276.37M 35.52% | 531.92M 92.47% | 1.23B 132.06% | 1.42B 15.32% | |
change in working capital | -75.38M - | -39.91M 47.05% | -206.44M 417.25% | -149.46M 27.60% | -245.74M 64.42% | -216.06M 12.07% | -367.06M 69.89% | -963.33M 162.44% | -974.47M 1.16% | ||
accounts receivables | -649.52M - | -1.40B 115.82% | -1.44B 2.79% | -1.50B 4.10% | |||||||
inventory | -38.40M - | -101.16M 163.47% | -51.15M 49.44% | -138.91M 171.60% | -95.68M 31.12% | -94.00M 1.75% | -704.52M 649.45% | -783.18M 11.17% | -498.12M 36.40% | ||
accounts payables | 649.52M - | 1.40B 115.82% | 1.44B 2.79% | 1.50B 4.10% | |||||||
other working capital | -36.98M - | 61.25M 265.62% | -155.29M 353.55% | -10.55M 93.21% | -150.05M 1,322.31% | -122.06M 18.66% | 337.46M 376.47% | -180.14M 153.38% | -476.35M 164.43% | ||
other non cash items | 794K - | -2.21M 378.09% | -28.22M 1,178.13% | 18.23M 164.60% | -2.52M 113.83% | -63.27M 2,408.80% | -74.95M 18.45% | -45.13M 39.79% | -876.68M 1,842.70% | -4.82B 450.17% | |
net cash provided by operating activities | 21.50M - | 107.15M 398.26% | 81.92M 23.55% | 360.28M 339.79% | 761.61M 111.39% | 1.21B 58.62% | 1.88B 55.72% | 3.43B 82.39% | 5.54B 61.51% | ||
investments in property plant and equipment | -51.04M - | -334.36M 555.05% | -428.88M 28.27% | -687.73M 60.35% | -1.83B 166.16% | -3.23B 76.71% | -6.02B 86.26% | -6.52B 8.27% | -5.87B 10.04% | ||
acquisitions net | 17.13M - | 489.90M 2,760.21% | -300.82M 161.40% | -155.24M 48.39% | -2.54B 1,533.05% | -131.49M 94.81% | |||||
purchases of investments | -2.82B - | -1.06B 62.57% | -4.64B 339.04% | -20.35B 338.50% | -59.30B 191.35% | -10.77B 81.84% | |||||
sales maturities of investments | 26.69M - | 1.28B 4,679.22% | 2.33B 83.06% | 3.91B 67.62% | 19.25B 391.88% | 58.24B 202.56% | 10.49B 82.00% | ||||
other investing activites | 924K - | -1.85M 300.65% | -18.95M 922.01% | 6.59M 134.80% | -353.08M 5,454.53% | -230.46M 34.73% | 67.11M 129.12% | 512.79M 664.12% | 377.56M 26.37% | ||
net cash used for investing activites | -50.12M - | -336.22M 570.82% | -421.14M 25.26% | -2.21B 425.53% | -416.07M 81.20% | -4.49B 980.08% | -7.22B 60.58% | -9.60B 33.06% | -5.91B 38.47% | ||
debt repayment | -4.42M - | -4.41M 0.36% | -468.86M 10,536.55% | -1.48B 215.13% | -140M - | -300.78M 114.84% | -728.27M 142.13% | -2.56B 251.95% | |||
common stock issued | 24M - | 3.57B - | 3.23B 9.73% | 3.60B 11.50% | 5.65B 57.07% | 11.04B 95.35% | 36.18M 99.67% | ||||
common stock repurchased | -2.52B - | -2.80B 11.42% | |||||||||
dividends paid | -18.06M - | ||||||||||
other financing activites | 10.86M - | 399.87M 3,582.02% | 801.62M 100.47% | 133.90M 83.30% | -18.64M 113.92% | 1.96B 10,598.27% | 1.22B 37.77% | 419.53M 65.54% | 2.74B 553.06% | ||
net cash used provided by financing activities | 30.44M - | 377.40M 1,139.98% | 332.76M 11.83% | 2.23B 569.94% | 3.21B 43.85% | 5.41B 68.79% | 6.57B 21.30% | 8.21B 25.04% | -2.59B 131.57% | ||
effect of forex changes on cash | -49K - | 3.95M 8,155.10% | 17.33M 339.14% | -41.56M 339.76% | 28.16M 167.76% | -5.87M 120.85% | -340.40M 5,697.96% | -131.50M 61.37% | 350.11M 366.24% | ||
net change in cash | 1.77M - | 152.28M 8,493.74% | 10.87M 92.86% | 334.78M 2,978.99% | 3.58B 969.52% | 2.12B 40.76% | 890.24M 58.03% | 1.91B 114.27% | -2.61B 236.72% | ||
cash at beginning of period | 4.18M - | 5.95M 42.43% | 158.23M 2,560.21% | 169.10M 6.87% | 503.88M 197.97% | 4.08B 710.59% | 6.21B 51.93% | 7.10B 14.35% | 9.00B 26.88% | 6.40B 28.97% | |
cash at end of period | 5.95M - | 158.23M 2,560.21% | 169.10M 6.87% | 503.88M 197.97% | 4.08B 710.59% | 6.21B 51.93% | 7.10B 14.35% | 9.00B 26.88% | 6.40B 28.97% | 6.40B 0% | |
operating cash flow | 21.50M - | 107.15M 398.26% | 81.92M 23.55% | 360.28M 339.79% | 761.61M 111.39% | 1.21B 58.62% | 1.88B 55.72% | 3.43B 82.39% | 5.54B 61.51% | ||
capital expenditure | -51.04M - | -334.36M 555.05% | -428.88M 28.27% | -687.73M 60.35% | -1.83B 166.16% | -3.23B 76.71% | -6.02B 86.26% | -6.52B 8.27% | -5.87B 10.04% | ||
free cash flow | -29.54M - | -227.21M 669.19% | -346.96M 52.70% | -327.45M 5.62% | -1.07B 226.43% | -2.03B 89.60% | -4.14B 104.46% | -3.09B 25.38% | -326.72M 89.43% |
All numbers in (except ratios and percentages)